Published in Int J Exp Pathol on August 12, 2014
Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4(+)CD25(-)CD69(+) subset proliferation. Drug Des Devel Ther (2016) 0.80
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development. J Clin Transl Hepatol (2015) 0.76
Trichloroethylene exposure reduces liver injury in a mouse model of primary biliary cholangitis. Toxicol Sci (2017) 0.75
Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models? Int J Mol Sci (2016) 0.75
Branched chain α-ketoacid dehydrogenase kinase 111-130, a T cell epitope that induces both autoimmune myocarditis and hepatitis in A/J mice. Immun Inflamm Dis (2017) 0.75
Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity (2007) 5.73
Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00
Biological interaction between lymphocytes and other cells. Br J Haematol (1956) 4.70
A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest (1992) 4.39
Follicular helper T cells are required for systemic autoimmunity. J Exp Med (2009) 4.25
PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol (2010) 3.51
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med (2000) 3.26
Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science (1990) 3.26
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med (1971) 3.23
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med (2005) 3.10
Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A (2000) 3.03
Local control of the immune response in the liver. Immunol Rev (2000) 3.01
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol (2012) 2.32
Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology (2014) 2.29
Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology (1996) 2.27
Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology (1995) 2.21
Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells. Hepatology (2013) 2.12
Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur J Immunol (2000) 2.09
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet (2000) 2.01
Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci U S A (2011) 1.89
Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol (2010) 1.86
Mixed cryoimmunoglobulinaemia in infectious mononucleois and Cytomegalovirus mononucleosis. Int Arch Allergy Appl Immunol (1968) 1.84
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med (2008) 1.76
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol (2006) 1.70
Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol (2011) 1.61
Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology (2010) 1.58
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology (1990) 1.57
Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest (2013) 1.57
Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol (2001) 1.47
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci U S A (1989) 1.44
Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection. Clin Exp Immunol (1975) 1.44
Electron microscopy of emperipolesis. J Biophys Biochem Cytol (1959) 1.41
The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J Virol (1996) 1.40
Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology (2009) 1.34
Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One (2011) 1.27
Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J Immunol (2008) 1.25
Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur J Immunol (1998) 1.24
TRAF molecules in cell signaling and in human diseases. J Mol Signal (2013) 1.22
Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology (1996) 1.12
Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology (2008) 1.11
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10
Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol (2002) 1.10
Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis. Hepatology (2007) 1.10
Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol (2001) 1.10
NOD mice and autoimmunity. Autoimmun Rev (2005) 1.09
The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology (2012) 1.09
Autoimmune hepatitis experimental model based on adenoviral infections. Hepatology (2013) 1.08
Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci (1995) 1.08
Follicular helper T cells: new insights into mechanisms of autoimmune diseases. Ochsner J (2013) 1.08
Experimental hepatitis and role of cytokines. Acta Gastroenterol Belg (1997) 1.05
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int (2010) 1.05
A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens. Hepatology (2004) 1.05
Aetiopathogenesis of autoimmune hepatitis. J Autoimmun (2009) 1.04
Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae. Gastroenterology (1983) 1.02
Pathogenesis of autoimmune hepatitis. Clin Liver Dis (2002) 1.00
Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance. Hepatology (2012) 0.99
Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol (2008) 0.99
IL-17RA is essential for optimal localization of follicular Th cells in the germinal center light zone to promote autoantibody-producing B cells. J Immunol (2013) 0.99
Update on autoimmune hepatitis. World J Gastroenterol (2009) 0.98
Study of cellular immunity in experimental autoimmune hepatitis in mice. Clin Exp Immunol (1984) 0.97
Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. J Hepatol (1994) 0.97
Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am J Physiol Gastrointest Liver Physiol (2002) 0.96
CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes. Eur J Immunol (2002) 0.95
Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology (2008) 0.95
Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus. Clin Exp Immunol (1983) 0.95
Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells. J Hepatol (2012) 0.93
Hepatitis resulting from liver-specific expression and recognition of self-antigen. J Autoimmun (2008) 0.92
Autoimmune liver diseases in children - what is different from adulthood? Best Pract Res Clin Gastroenterol (2011) 0.91
DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis. J Immunol (2002) 0.91
Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis. Gastroenterology (2010) 0.90
A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology (2004) 0.89
End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas. J Immunol (2009) 0.88
Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route. Exp Anim (2008) 0.88
Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model. J Autoimmun (2011) 0.88
Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun (2005) 0.87
Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis. Liver Int (2013) 0.86
Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. Am J Pathol (2010) 0.85
Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation. Clin Immunol (2010) 0.85
Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance. J Immunol (1990) 0.84
Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12. Clin Immunol (2005) 0.82
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteomics (2012) 0.82
Mouse models for experimental autoimmune hepatitis: limits and chances. Dig Dis (2010) 0.81
Dissecting genetic control of autoimmunity in NOD congenic mice. Immunol Res (2006) 0.81
Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection. J Clin Pathol (1994) 0.81
HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor. Sci Rep (2013) 0.80
Current trends in the diagnosis and treatment of autoimmune hepatitis in Japan. Hepatol Res (2011) 0.79
IL-17 contributes to autoimmune hepatitis. J Huazhong Univ Sci Technolog Med Sci (2010) 0.79
Studies on the pathogenesis of murine experimental autoimmune active hepatitis: sensitized T cell involvement in its induction. Clin Exp Immunol (1987) 0.79
Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2. Drug Metab Rev (2005) 0.79
Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand. J Immunol (2012) 0.78
Histology of autoimmune hepatitis and its variants. Clin Liver Dis (2010) 0.78
Coincidence of autoantibody production with the activation of natural killer T cells in α-galactosylceramide-mediated hepatic injury. Immunology (2011) 0.78
Endothelial cells are damaged by autophagic induction before hepatocytes in Con A-induced acute hepatitis. Int Immunol (2010) 0.78
Insulin2 gene (Ins2) transcription by NOD bone marrow-derived cells does not influence autoimmune diabetes development in NOD-Ins2 knockout mice. Scand J Immunol (2009) 0.78
A two-step model for the induction of organ-specific autoimmunity. Novartis Found Symp (1998) 0.78
Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6. J Autoimmun (2013) 0.78
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet (2007) 8.63
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol (2012) 3.88
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet (2010) 3.22
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest (2007) 2.81
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology (2002) 2.54
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. Eur J Gastroenterol Hepatol (2006) 2.47
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology (2012) 2.46
Angiogenesis in liver disease. J Hepatol (2008) 2.31
Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med (2004) 2.29
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell (2010) 2.26
The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension. Cardiovasc Res (2013) 2.08
MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol (2010) 1.79
Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol (2009) 1.79
Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes (2004) 1.76
Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity (2002) 1.74
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. Hepatology (2003) 1.73
Therapeutic targeting of Syk in autoimmune diabetes. J Immunol (2010) 1.69
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice. Hepatology (2011) 1.65
Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components. Transfusion (2011) 1.59
The need for transparency and good practices in the qPCR literature. Nat Methods (2013) 1.58
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl (2006) 1.57
188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med (2005) 1.52
Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med (2003) 1.52
Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital. Eur J Nucl Med Mol Imaging (2011) 1.50
Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Transfusion (2006) 1.50
Alteration of protein glycosylation in liver diseases. J Hepatol (2008) 1.47
The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns. AIDS (2008) 1.42
Angiogenesis in chronic liver disease and its complications. Liver Int (2010) 1.41
Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values. Liver Transpl (2013) 1.41
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A (2002) 1.40
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study. J Hepatol (2012) 1.35
Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (2002) 1.31
West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion (2014) 1.30
miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol (2011) 1.28
Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant (2005) 1.26
Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg (2003) 1.26
Phosphorylation and kinetics of mammalian cytochrome c oxidase. Mol Cell Proteomics (2008) 1.24
The paradox of the unfolded protein response in cancer. Anticancer Res (2013) 1.21
Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J Autoimmun (2002) 1.20
How reliable is pain as the fifth vital sign? J Am Board Fam Med (2009) 1.16
The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J Immunol (2004) 1.15
Regulation of mitochondrial uncoupling respiration during exercise in rat heart: role of reactive oxygen species (ROS) and uncoupling protein 2. Free Radic Biol Med (2008) 1.13
B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes. Diabetes (2008) 1.12
Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients. Clin Vaccine Immunol (2011) 1.10
Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice. J Immunol (2009) 1.10
A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes (2002) 1.10
Response of mitochondrial fusion and fission protein gene expression to exercise in rat skeletal muscle. Biochim Biophys Acta (2009) 1.10
Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin Chem (2010) 1.09
TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest (2006) 1.09
Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Transfusion (2011) 1.09
Toll-like receptors and diabetes. Ann N Y Acad Sci (2008) 1.09
Secreted frizzled-related protein disrupts PCP in eye lens fiber cells that have polarised primary cilia. Dev Biol (2009) 1.08
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. J Clin Invest (2011) 1.07
Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. J Immunol (2010) 1.05
Factors associated with clinician intention to address diverse aspects of pain in seriously ill outpatients. Pain Med (2010) 1.05
FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients. Lung Cancer (2012) 1.04
Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes. Diabetes (2009) 1.04
The value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc (2007) 1.03
Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening. Transfusion (2011) 1.02
Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. Int J Exp Pathol (2008) 1.02
Damage of oxidative stress on mitochondria during microspores development in Honglian CMS line of rice. Plant Cell Rep (2006) 1.01
The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Ann N Y Acad Sci (2008) 1.01
Clear cell tumor of the lung: a case report and literature review. World J Surg Oncol (2013) 1.01
Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. J Proteome Res (2009) 1.00
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice. J Autoimmun (2009) 1.00
Early identification of co-occurring pain, depression and anxiety. J Gen Intern Med (2009) 1.00
Inhibition of AMP-activated protein kinase protects pancreatic beta-cells from cytokine-mediated apoptosis and CD8+ T-cell-induced cytotoxicity. Diabetes (2007) 0.99
Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol Ecol (2011) 0.98
Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents. Lab Invest (2010) 0.98